JP Morgan Maintains Overweight on Solid Biosciences, Raises Price Target to $12
Benzinga Newsdesk 7 months ago
NewsPrice TargetAnalyst Ratings
JP Morgan analyst Anupam Rama maintains Solid Biosciences (NASDAQ:SLDB) with a Overweight and raises the price target from $11 to $12.
JP Morgan analyst Anupam Rama maintains Solid Biosciences (NASDAQ:SLDB) with a Overweight and raises the price target from $11 to $12.